Meds Apotek AB (STO:MEDS)
Sweden · Delayed Price · Currency is SEK 22.20
-0.20 (-0.89%)
At close: Jun 12, 2026
Meds Apotek AB Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Meds Apotek AB stock has a consensus rating of "Strong Buy" and an average price target of kr 47.50. The average 1-year stock price forecast is 113.96% higher than the current stock price, while the lowest is kr 40.00 (+80.18%) and the highest is kr 55.00 (+147.75%).
Price Target: kr 47.50 (+113.96%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Meds Apotek AB stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Apr '26 | May '26 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 2 | 2 |
Financial Forecast
Revenue This Year
1.12B
from 1.01B
Increased by 11.24%
Revenue Next Year
1.31B
from 1.12B
Increased by 16.79%
EPS This Year
1.48
from 0.84
Increased by 76.16%
EPS Next Year
2.43
from 1.48
Increased by 64.41%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is SEK.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.1B | ||
| Avg | 1.1B | ||
| Low | 1.1B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 12.8% | ||
| Avg | 11.2% | ||
| Low | 9.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.66 | ||
| Avg | 1.48 | ||
| Low | 1.29 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 98.3% | ||
| Avg | 76.2% | ||
| Low | 54.1% |